SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

crow with knife is generating intense community interest due to its unique multichain presence and deflationary burn mechanism. Supporters are actively rallying behind the project's organic growth and cultural identity, frequently encouraging others to increase their positions in what they describe as a community-driven movement.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the news that Greenland has approved the transfer of a majority interest in the Tanbreez project, bringing the company's total ownership to 92.5%. The community is actively discussing the potential for a significant short squeeze given the high short interest, while expressing bullish sentiment on the asset's strategic value for Western supply chains and its potential for a long-term revaluation.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares are facing significant volatility following an orbital insertion failure during a Blue Origin launch, where the latest BlueBird satellite was placed into an unsustainable low orbit. The community is actively debating the reliability of Blue Origin as a launch partner compared to SpaceX, while long-term investors are highlighting the company's insurance coverage and the upcoming backlog of satellites as reasons to maintain their bullish thesis.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is generating significant investor buzz following its recent NYSE IPO, with market participants closely monitoring the drone manufacturer due to its strong defense sector positioning and ongoing government contract activity. Community discussion is focused on the stock's high-volatility momentum, with traders actively comparing its growth potential to other defense technology players while debating the sustainability of its post-debut price action.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility as the community trades on news surrounding a presidential executive order expected to fast-track research for psychedelic therapies, specifically ibogaine. While bulls are anticipating a significant short squeeze due to the stock's small float and high short interest, bears are highlighting risks like potential share dilution and concerns that the news is already priced into the valuation.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is capturing significant investor attention as it evolves into a full-stack 'Physical AI' platform following its acquisition of Stereolabs, with sentiment shifting toward its long-term potential in industrial automation, robotics, and smart infrastructure. Community discussions are currently dominated by analysis of the company's path to profitability, the strategic advantages of its sensor-software integration, and the impact of domestic sourcing policies on future market dominance.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased investor activity and bullish sentiment as the community anticipates critical updates on fiscal guidance, royalty backlogs, and revenue growth in upcoming financial reports. Investors are highlighting BlackBerry's pivotal role as a safety-certified foundation for physical AI and software-defined vehicles, driven by expanding partnerships with major automotive and robotics manufacturers.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors in SOXS are expressing intense frustration as the semiconductor sector continues its prolonged rally, fueled by FOMO and AI-driven exuberance despite significant geopolitical tensions in the Middle East. The community is heavily divided, with many trapped in losing short positions and debating whether the recent market climb represents a sustainable trend or an imminent bubble that is ripe for a sharp reversal.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors rally behind its pivotal role in the AI infrastructure and semiconductor space, bolstered by strategic partnerships with major tech leaders and positive analyst sentiment. The community remains heavily focused on the company's expansion into custom AI silicon and optics, with many debating whether the current momentum represents a long-term re-rating or a temporary peak.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of intense debate as community members weigh recent flight telemetry data and legal maneuverings against the company's progress toward commercial launch. Sentiment remains sharply divided, with some investors highlighting the potential of the air taxi sector and strategic partnerships, while others express skepticism over testing milestones and the stock's recent performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up   - What's Next?

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's What Happened...

Baillie Gifford & Co. Sells 4,827,438 Shares of Sana Biotechnology, Inc. $SANA

Baillie Gifford & Co. lessened its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the...

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.read more...

<ul class="summary-bullets"><li>Sana expects to seek the U.S. Food and Drug Administration’s clearance to start clinical trials and begin early stage trials for it as early as this year.&nbsp;</li><li>Sana on Monday said that Mayo purchased 7.5 million shares of the company’s common stock at a price of $3.33 per share for gross proceeds of about $25 million under the deal.</li><li>The purchase price under the agreement implies a potential upside of about 4% from the stock's closing price on Monday.</li></ul><p>Shares of Sana Biotechnology, Inc. (SANA) jumped 24% after-hours on Monday after the company announced a strategic collaboration with Mayo Clinic that involves an equity investment by the latter. &nbsp;</p><p>The agreement is aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes. The company expects to seek the U.S. Food and Drug Administration’s clearance to start clinical trials and begin early stage trials for it as early as this year.</p><p>Sana’s SC451 is designed to support long-term glucose control without the need for ongoing insulin therapy in type 1 diabetes patients. The agreement with Mayo is aimed at accelerating development, validation, and standardization of protocols and processes for SC451, and supporting safe, scalable, and consistent delivery across diverse clinical environments.</p><h2 class="st-heading-2">Equity Investment in Sana Biotechnology by Mayo</h2><p>Sana on Monday said that Mayo purchased 7.5 million shares of the company’s common stock at a price of $3.33 per share for gross proceeds of about $25 million under the deal. It also noted that Mayo would have the option to make an additional equity investment of $25 million as part of the collaboration.</p><p>The closing of the sale of the initial $25 million worth of shares is expected to occur on or about April 15, Sana said. &nbsp;</p><p>The purchase price under the agreement implies a potential upside of about 4% from the stock's closing price on Monday and nearly 8% from the closing price on Friday.</p><h2 class="st-heading-2">Wall Street Take</h2><p>According to data from Koyfin, eight of the nine analysts covering SANA rate it ‘Buy’ or higher, while one rates it ‘Hold.’ The 12-month average price target on the stock is $8.43, representing a potential upside of about 163% from the stock’s last closing price.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around SANA stock rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘normal’ levels.</p><p><a href="https://stocktwits.com/symbol/SANA">SANA stock</a> has gained 77% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/abde-stock-poised-for-best-rally-in-over-a-year-michael-burry/cZJ87RBRIuv">ABDE Stock Poised For Best Rally In Over A Year — What’s Michael Burry Got To Do With It?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Last week, Baird maintained AYI’s ‘neutral’ rating but cut price target to $320 from $375. (Representative image: Getty Images)

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.

Equity

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.


Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...

JPMorgan Chase & Co. Raises Holdings in Sana Biotechnology, Inc. $SANA

JPMorgan Chase & Co. lifted its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 180.8% during the third quarter, according to the company in its most recent Form 13F filing with...

Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.2% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and s...

Sana Biotechnology (NASDAQ:SANA) Trading Up 7.8% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Trading 7.8% Higher - Still a Buy...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.16	--	--	N/A
Q4 '25	-$0.14	-$0.21	-47.75%	MISSED
Q3 '25	-$0.19	-$0.16	15.23%	BEAT
Q2 '25	-$0.20	-$0.39	-94.27%	MISSED
Q1 '25	-$0.22	-$0.21	4.26%	BEAT

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest SANA News

SANASana Biotechnology Inc